MyAverix Finance
VN · Healthcare
Cuu Long Pharmaceutical JSC (DCL)
Drug Manufacturers - Specialty & Generic
Cuu Long Pharmaceutical JSC (DCL) is listed on VN in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DCL
Cuu Long Pharmaceutical JSC (DCL) — FAQ
What is DCL's P/E ratio?
The price-to-earnings (P/E) ratio for Cuu Long Pharmaceutical JSC (DCL) is 18.00 (data as of 2026-03-23).
Does Cuu Long Pharmaceutical JSC pay a dividend?
Dividend yield is not available in the current snapshot for Cuu Long Pharmaceutical JSC (DCL). Check the MyAverix Finance app for the latest dividend data.
What sector is Cuu Long Pharmaceutical JSC in?
Cuu Long Pharmaceutical JSC (DCL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is DCL listed on?
DCL is listed on VN.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.